Patients’ characteristics
| Sex . | Age (y) . | Clinical status . |
|---|---|---|
| F | 62 | VGPR |
| M | 77 | sCR |
| F | 57 | sCR |
| M | 56 | sCR |
| F | 45 | PD |
| F | 55 | CLR |
| M | 41 | PR |
| M | 41 | sCR |
| F | 50 | PD |
| M | 74 | sCR |
| F | 55 | VGPR |
| F | 59 | SD |
| F | 47 | sCR |
| M | 59 | sCR |
| M | 70 | SD |
| M | 46 | sCR |
| F | 62 | sCR |
| M | 43 | sCR |
| M | 36 | CR |
| M | 41 | sCR |
| M | 63 | SD |
| M | 68 | CR |
| F | 75 | CLR |
| F | 64 | CR |
| M | 54 | sCR |
| F | 58 | CR |
| M | 69 | sCR |
| M | 70 | VGPR |
| F | 30 | PR |
| F | 70 | sCR |
| F | 51 | sCR |
| F | 80 | PR |
| F | 64 | PD |
| F | 43 | Diagnostic |
| M | 66 | PR |
| F | 54 | Unknown |
| F | 60 | VGPR |
| M | 64 | sCR |
| F | 54 | CR |
| M | 83 | PR |
| M | 65 | PD |
| Sex . | Age (y) . | Clinical status . |
|---|---|---|
| F | 62 | VGPR |
| M | 77 | sCR |
| F | 57 | sCR |
| M | 56 | sCR |
| F | 45 | PD |
| F | 55 | CLR |
| M | 41 | PR |
| M | 41 | sCR |
| F | 50 | PD |
| M | 74 | sCR |
| F | 55 | VGPR |
| F | 59 | SD |
| F | 47 | sCR |
| M | 59 | sCR |
| M | 70 | SD |
| M | 46 | sCR |
| F | 62 | sCR |
| M | 43 | sCR |
| M | 36 | CR |
| M | 41 | sCR |
| M | 63 | SD |
| M | 68 | CR |
| F | 75 | CLR |
| F | 64 | CR |
| M | 54 | sCR |
| F | 58 | CR |
| M | 69 | sCR |
| M | 70 | VGPR |
| F | 30 | PR |
| F | 70 | sCR |
| F | 51 | sCR |
| F | 80 | PR |
| F | 64 | PD |
| F | 43 | Diagnostic |
| M | 66 | PR |
| F | 54 | Unknown |
| F | 60 | VGPR |
| M | 64 | sCR |
| F | 54 | CR |
| M | 83 | PR |
| M | 65 | PD |
CLR, clinical relapse; CR, complete response; F, female; M, male; PD, progressive disease; PR, partial response; sCR, stringent complete response; SD, stable disease; VGPR, very good partial response.